Liu Linli
Department of Gynecology, Fuzhou First General Hospital, Affiliated to Fujian Medical University, Taijiang District, Fuzhou, Fujian, People's Republic of China.
Risk Manag Healthc Policy. 2024 Dec 4;17:2959-2970. doi: 10.2147/RMHP.S481880. eCollection 2024.
Endometrial cancer (EC) is one of the most frequent gynecologic cancers, approximately 20% of patients are regarded as high-risk with poor prognosis. However, more details of patients with second primary endometrial cancer (SPEC) after colorectal cancer (CRC) remain poorly understood. We therefore proposed to construct two nomograms to predict 3- and 5-year overall survival (OS) and cancer-specific survival (CSS) rates to facilitate clinical application.
A total of 1631 participants were identified in the SEER database from 1973 to 2020. We constructed and validated the nomograms for predicting OS and CSS. The receiver operating characteristic curves, calibration plot, decision curve analysis, C-index, net reclassification improvement, and integrated discrimination improvement were applied to evaluate the predictive performance. Finally, the Prognostic index was calculated and used for risk stratification of Kaplan-Meier survival analysis based on different treatment options.
Nomograms of OS and CSS were formulated based on the independent prognostic factors utilizing the training set. The 3- and 5- years of OS nomogram demonstrated good discrimination (AUC = 0.840 and 0.829, respectively), well-calibrated power, and excellent clinical effectiveness. Our nomograms of predicting OS and CSS had a concordance index of 0.801 and 0.866 compared with 0.676 and 0.746 for the AJCC staging system, and more importantly, demonstrated a better forecast accuracy. Chemoradiotherapy displayed a significant survival benefit in the high-risk groups, but proceeding to surgery plus chemotherapy showed a favorable survival for the low groups based on all patients.
We developed and internally validated multivariable models that predict OS and CSS risk of SPEC in patients with a CRC to help clinicians make applicable clinical decisions for patients.
子宫内膜癌(EC)是最常见的妇科癌症之一,约20%的患者被视为高危且预后不良。然而,结直肠癌(CRC)后发生第二原发性子宫内膜癌(SPEC)患者的更多细节仍知之甚少。因此,我们建议构建两个列线图来预测3年和5年总生存率(OS)和癌症特异性生存率(CSS),以促进临床应用。
在1973年至2020年的SEER数据库中识别出总共1631名参与者。我们构建并验证了用于预测OS和CSS的列线图。应用受试者工作特征曲线、校准图、决策曲线分析、C指数、净重新分类改善和综合判别改善来评估预测性能。最后,计算预后指数并用于基于不同治疗方案的Kaplan-Meier生存分析的风险分层。
利用训练集基于独立预后因素制定了OS和CSS的列线图。3年和5年OS列线图显示出良好的辨别力(AUC分别为0.840和0.829)、良好的校准能力和出色的临床有效性。我们预测OS和CSS的列线图的一致性指数分别为0.801和0.866,而AJCC分期系统的一致性指数为0.676和0.746,更重要的是,显示出更好的预测准确性。放化疗在高危组中显示出显著的生存益处,但基于所有患者,进行手术加化疗对低危组显示出良好的生存情况。
我们开发并在内部验证了多变量模型,该模型可预测CRC患者中SPEC的OS和CSS风险,以帮助临床医生为患者做出适用的临床决策。